Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01483274
Title Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Louisville
Indications

acute myeloid leukemia

Therapies

Decitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.